Trial Profile

A retrospective analysis of Alveolar soft part sarcoma patients treated with chemotherapy and antiangiogenic therapy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Doxorubicin (Primary) ; Ifosfamide (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary)
Indications Alveolar soft part sarcoma
Focus Therapeutic Use

Most Recent Events

01 Jan 2025 Results (n=227) assessing long-term outcomes of patients treated with cladribine tablets, presented in the Multiple Sclerosis Journal
24 Jun 2019 New trial record
04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com